Speech Pathology Department & Intensive Care Unit, Concord Repatriation General Hospital, NSW, Australia; Faculty of Health Sciences, The University of Sydney, NSW, Australia; School of Health & Rehabilitation Sciences, The University of Queensland, QLD, Australia.
Speech Pathology Department & Intensive Care Unit, Royal Prince Alfred Hospital, NSW, Australia.
Aust Crit Care. 2023 Mar;36(2):262-268. doi: 10.1016/j.aucc.2022.01.001. Epub 2022 Jan 14.
The impact of COVID-19 on swallowing function is not well understood. Despite low hospital admission rates in Australia, the virus and subsequent treatment affects swallow function in those requiring intensive care unit (ICU) treatment. As such, the current pandemic provides a unique opportunity to describe swallowing function and outline dysphagia characteristics and trajectory of recovery for a series of cases across NSW.
The aims of this study were to describe (i) physiological characteristics of swallowing dysfunction and (ii) pattern of swallowing recovery and outcomes, in ICU patients with COVID-19.
All patients admitted to 17 participating NSW Health ICU sites over a 12-month period (March 2020-March 2021), diagnosed with COVID-19, treated with the aim for survival, and seen by a speech pathologist for clinical swallowing examination during hospital admission were considered for inclusion. Demographic, critical care airway management, speech pathology treatment, and swallowing outcome data were collected.
Twenty-seven patients (22 male; 5 female) with a median age of 65 years (interquartile range [IQR] = 15.5) were recruited. All required mechanical ventilation. Almost 90% of the total cohort had pre-existing comorbidities, with the two most frequently observed being diabetes (63%, 95% confidence interval = 44%-78%) and cardiac disease (59%, 95% confidence interval = 40%-75%) in origin. Prevalence of dysphagia was 93%, with the majority (44%) exhibiting profound dysphagia at the initial assessment. Median duration to initiate oral feeding was 38.5 days (IQR = 31.25) from ICU admission, and 33% received dysphagia rehabilitation. Dysphagia recovery was observed in 81% with a median duration of 44 days (IQR = 29). Positive linear associations were identified between duration of intubation, mechanical ventilation, hospital and ICU length of stay, and the duration to speech pathology assessment (p < 0.005), dysphagia severity (p < 0.002), commencing oral intake (p < 0.02), dysphagia recovery (p < 0.004), and enteral feeding (p < 0.024).
COVID-19 considerably impacted swallowing function in the current study. Although many patients recovered within an acceptable timeframe, some experienced persistent severe dysphagia and a protracted recovery with dependence on enteral nutrition.
COVID-19 对吞咽功能的影响尚未被充分了解。尽管澳大利亚的住院率较低,但该病毒及其后续治疗会影响到需要重症监护病房(ICU)治疗的人群的吞咽功能。因此,当前的大流行提供了一个独特的机会,可以描述新南威尔士州一系列病例的吞咽功能,并概述吞咽困难的特征和恢复轨迹。
本研究的目的是描述(i)COVID-19 患者吞咽功能障碍的生理特征,以及(ii)吞咽恢复和结局的模式。
在 2020 年 3 月至 2021 年 3 月的 12 个月期间,所有在新南威尔士州健康 ICU 参与的 17 个地点住院、被诊断为 COVID-19、并接受旨在生存的治疗、以及在住院期间接受言语病理学家进行临床吞咽检查的患者均被认为符合纳入标准。收集人口统计学、重症监护气道管理、言语病理学治疗和吞咽结局数据。
共纳入 27 名患者(22 名男性;5 名女性),中位年龄为 65 岁(四分位距[IQR] = 15.5)。所有患者均需要机械通气。几乎 90%的患者有预先存在的合并症,最常观察到的两种是糖尿病(63%,95%置信区间[CI] = 44%-78%)和心脏病(59%,95%CI = 40%-75%)。吞咽困难的患病率为 93%,大多数(44%)在初始评估时表现出严重的吞咽困难。从 ICU 入院到开始口服喂养的中位时间为 38.5 天(IQR = 31.25),33%的患者接受了吞咽困难康复治疗。81%的患者观察到吞咽困难恢复,中位恢复时间为 44 天(IQR = 29)。在插管、机械通气、住院和 ICU 住院时间、言语病理评估时间(p < 0.005)、吞咽困难严重程度(p < 0.002)、开始口服摄入(p < 0.02)、吞咽困难恢复(p < 0.004)和肠内喂养(p < 0.024)方面,均观察到与时间呈正相关线性关系。
在本研究中,COVID-19 对吞咽功能产生了显著影响。尽管许多患者在可接受的时间内恢复,但有些患者经历了持续的严重吞咽困难和长时间的恢复,需要依赖肠内营养。